These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9714914

  • 41. Heregulins and the ErbB-2/3/4 receptors in gliomas.
    Westphal M, Meima L, Szonyi E, Lofgren J, Meissner H, Hamel W, Nikolics K, Sliwkowski MX.
    J Neurooncol; 1997 Dec; 35(3):335-46. PubMed ID: 9440030
    [Abstract] [Full Text] [Related]

  • 42. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors.
    Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR.
    Neuron; 1995 Sep; 15(3):585-96. PubMed ID: 7546738
    [Abstract] [Full Text] [Related]

  • 43. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
    Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y.
    Mol Cell Biol; 1996 Oct; 16(10):5276-87. PubMed ID: 8816440
    [Abstract] [Full Text] [Related]

  • 44. Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function.
    Raabe TD, Suy S, Welcher A, DeVries GH.
    J Neurosci Res; 1997 Dec 01; 50(5):755-68. PubMed ID: 9418963
    [Abstract] [Full Text] [Related]

  • 45. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG, Hosick HL, Ethier SP.
    J Cell Physiol; 2000 Jun 01; 183(3):301-13. PubMed ID: 10797304
    [Abstract] [Full Text] [Related]

  • 46. ErbB-4 activation promotes neurite outgrowth in PC12 cells.
    Vaskovsky A, Lupowitz Z, Erlich S, Pinkas-Kramarski R.
    J Neurochem; 2000 Mar 01; 74(3):979-87. PubMed ID: 10693928
    [Abstract] [Full Text] [Related]

  • 47. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 48. A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4.
    Higashiyama S, Horikawa M, Yamada K, Ichino N, Nakano N, Nakagawa T, Miyagawa J, Matsushita N, Nagatsu T, Taniguchi N, Ishiguro H.
    J Biochem; 1997 Sep 15; 122(3):675-80. PubMed ID: 9348101
    [Abstract] [Full Text] [Related]

  • 49. Bivalence of EGF-like ligands drives the ErbB signaling network.
    Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC, Yarden Y.
    EMBO J; 1997 Aug 15; 16(16):4938-50. PubMed ID: 9305636
    [Abstract] [Full Text] [Related]

  • 50. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.
    Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y.
    Cell; 1992 Apr 03; 69(1):205-16. PubMed ID: 1348215
    [Abstract] [Full Text] [Related]

  • 51. Proliferation of human Schwann cells induced by neu differentiation factor isoforms.
    Baek SY, Kim SU.
    Dev Neurosci; 1998 Apr 03; 20(6):512-7. PubMed ID: 9858839
    [Abstract] [Full Text] [Related]

  • 52. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
    Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y.
    EMBO J; 1996 Jan 15; 15(2):254-64. PubMed ID: 8617201
    [Abstract] [Full Text] [Related]

  • 53. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 15; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 54. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta.
    Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF.
    Oncogene; 1996 Jan 18; 12(2):345-53. PubMed ID: 8570211
    [Abstract] [Full Text] [Related]

  • 55. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 56. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y.
    Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426
    [Abstract] [Full Text] [Related]

  • 57. The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
    Waterman H, Alroy I, Strano S, Seger R, Yarden Y.
    EMBO J; 1999 Jun 15; 18(12):3348-58. PubMed ID: 10369675
    [Abstract] [Full Text] [Related]

  • 58. Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo.
    Grimm S, Weinstein EJ, Krane IM, Leder P.
    J Exp Med; 1998 Oct 19; 188(8):1535-9. PubMed ID: 9782131
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The effects of the normal and oncogenic forms of the neu tyrosine kinase, and the corresponding forms of an immunoglobulin E receptor/neu tyrosine kinase fusion protein, on Xenopus oocyte maturation.
    Narasimhan V, Hamill O, Cerione RA.
    FEBS Lett; 1992 Jun 01; 303(2-3):164-8. PubMed ID: 1351469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.